- Home
- BODI vs PASG Comparison
BODI vs PASG Comparison
Compare BODI & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- PASG
- Stock Information
- Founded
- BODI 1998
- PASG 2017
- Country
- BODI United States
- PASG United States
- Employees
- BODI N/A
- PASG N/A
- Industry
- BODI Industrial Machinery/Components
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- PASG Health Care
- Exchange
- BODI Nasdaq
- PASG Nasdaq
- Market Cap
- BODI 46.0M
- PASG 42.2M
- IPO Year
- BODI N/A
- PASG 2020
- Fundamental
- Price
- BODI $7.94
- PASG $0.52
- Analyst Decision
- BODI Strong Buy
- PASG Strong Buy
- Analyst Count
- BODI 3
- PASG 3
- Target Price
- BODI $12.33
- PASG $8.00
- AVG Volume (30 Days)
- BODI 11.8K
- PASG 138.4K
- Earning Date
- BODI 03-10-2025
- PASG 03-03-2025
- Dividend Yield
- BODI N/A
- PASG N/A
- EPS Growth
- BODI N/A
- PASG N/A
- EPS
- BODI N/A
- PASG N/A
- Revenue
- BODI $451,432,000.00
- PASG N/A
- Revenue This Year
- BODI N/A
- PASG N/A
- Revenue Next Year
- BODI N/A
- PASG N/A
- P/E Ratio
- BODI N/A
- PASG N/A
- Revenue Growth
- BODI N/A
- PASG N/A
- 52 Week Low
- BODI $5.14
- PASG $0.45
- 52 Week High
- BODI $11.31
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- BODI 62.87
- PASG 39.73
- Support Level
- BODI $6.51
- PASG $0.52
- Resistance Level
- BODI $8.01
- PASG $0.60
- Average True Range (ATR)
- BODI 0.61
- PASG 0.05
- MACD
- BODI 0.07
- PASG 0.00
- Stochastic Oscillator
- BODI 80.56
- PASG 20.37
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.